THE RELATIONSHIP OF ENA PROFILE AND SOME NEW IMMUNOLOGICAL MARKERS IN LUPUS NEPHRITIS PATIENTS IN KERBALA PROVINCE
DOI:
https://doi.org/10.53555/53kr3w41Keywords:
PLA2R: Phospholipase A2Receptor, ENA: Extractible Nuclear Antigen, ANA: Anti-Nuclear Antibody, anti-ds DNA: Anti-double strand deoxyribonucleic acid, VCAM: vascular cell adhesion molecule, NGAL: Neutrophil gelatinase associated Lipocaline, GN: Glomerular Nephritis, ESRD: End Stage Renal Disease.Abstract
Lupus nephritis is an immune complex Glomerular Nephritis (GN) that develops as a frequent complication of SLE, the pathogenesis of lupus nephritis involves a variety of pathogenic mechanisms. The external etiology of systemic lupus is based on multiple combinations of genetic variants that compromise those mechanisms normally assuring immune tolerance to nuclear auto antigens, the increased incidence of ESRD underlines the importance of early diagnosis in this difficult to control disease with unpredictable course
This study aimed to distinguished between the patients with primary glomerulonephritis from the secondary glomerulonephritis (SLE) by using the Phospholipase A2 receptor test (PLA2R), and aimed to use the ENA screen test to detect The patients with naïve SLE from the patient with SLE associated with other autoimmune disease, also measurement the the concentration of NGAL, VCAM, ANA, ds-DNA by using ELISA method, this research included eighty-five female patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Pharmacy and Biological Science (ISSN 2208-2360)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
